《新股消息》向中國際(01871.HK)公開超購379倍 一手中籤率1.6%
內地駕駛培訓服務供應商向中國際(01871.HK)公布發售1億股新股,原定公開發售佔10%,但公開發售部份錄得380.15倍申請,經重新分配後,相關部份發售股份數目增至5,000萬股,佔整體發售之50%。一手4,000股的中籤率僅1.6%。
向中國際公布發售價定於每股1.28元,為其招股價區間1.28元至1.42元之下限,集資淨額1.01億元。
公司早前公布,其中58%將用於擴大大型車輛培訓場地,12.7%用於償還銀行貸款,9.6%用作招聘及培訓大型車輛駕駛教練,9.7%用於購買新訓練車,其餘撥作一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.